|
Published by: Plunkett Research, Ltd.
Published: Apr. 25, 2007 - 1305 Pages
Table of Contents
- PLUNKETT’S HEALTH CARE INDUSTRY ALMANAC 2007
- A Short Health Care Industry Glossary
- Introduction
- How to Use This Book
- Chapter 1: Major Trends Affecting the Health Care Industry
- 1) Introduction to the Health Care Industry
- 2) Continued Rise in Health Care Costs
- 3) Employers Push Health Care Costs onto Employees
- 4) Medicare and Medicaid Spending Continue to Surge/ Baby Boomers Pass 65 Years of Age Soon
- 5) Medicare Changes Include Drug Benefits for Seniors/Medicare Advantage Offers Private Fee for Service Plans
- 6) Health Savings Accounts and Health Reimbursement Accounts Gain Traction
- 7) Vast Number of Uninsured and Underinsured Americans
- 8) Cost of Pharmaceuticals Soars in U.S., Controversy over Drug Prices Rages On
- 9) Critical Lack of Qualified Nurses in the U.S. Continues Despite Federal Efforts
- 10) Boom in Surgery Centers
- 11) Patients Are Seeking Quality of Care Data
- 12) Growing Use of Managed Care by Medicare
- 13) Malpractice Suits Are Blamed for Rising Health Care Costs/Tort Reform Is Capping Awards for Damages
- 14) Transplants Are Big Business
- 15) Hospitals are Reengineering
- 16) Obesity Sparks Government Action
- 17) Health Care Goes Offshore, Private Clinics Thrive in China and India
- 18) Disease Management Programs Take Root
- 19) Clinics Open in Retail Store Settings
- The Outlook for Health Care Technology
- 20) Health Care Technology Introduction
- 21) Information Technology and Health Care
- 22) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race
- 23) Stem Cell Funding Trickles at the Federal Level While a Few States Create Funding of Their Own
- 24) Stem Cells—Therapeutic Cloning Techniques Advance
- 25) Stem Cells—A New Era of Regenerative Medicine Takes Shape
- 26) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine
- 27) New Drug Delivery Systems
- 28) Advances in Cancer Research
- 29) Better Imaging, including MRI, PET and 64-Slice CT, Creates Advances in Detection
- 30) Molecular Imaging will Lead to Early Detection and Early Cure of Cancerous Tumors
- 31) Advances in Laboratory Testing
- 32) Advances in Surgery
- 33) Other Treatment Technologies
- Chapter 2: Health Care Industry Statistics
- I. U.S. Health Care Industry Overview
- U.S. Health Care Industry Overview
- Health Care Overview of OECD Developed Nations: 1993-2003
- Top 10 Global Health Insurance Companies by Revenues, 2005
- Employment, Hours and Earnings in Private Health Service Establishments by Type of Establishment, U.S. : 2001-2005
- II. U.S. Health Care Expenditures & Costs
- The Nation's Health Dollar, 2006 Where It Came From (Estimated)
- The Nation's Health Dollar, 2006, Where It Went (Estimated)
- National Health Expenditures and Average Annual Percent Change: Selected Calendar Years 1980-2015
- National Health Expenditures and Selected Economic Indicators, Levels and Average Annual Percent Change, U.S.: Selected Years 1990-2015
- National Health Expenditure Amounts, By Type of Expenditure, U.S.: Selected Calendar Years 1980-2015
- Hospital Care Expenditures and Average Annual Percent Change, U.S.: Selected Calendar Years 1980-2015
- Hospital Care Expenditures, Percent Distribution and Per Capita Amount, U.S.: Selected Calendar Years 1980-2015
- Home Health Care Expenditures and Average Annual Percent Change, U.S.: Selected Calendar Years 1980-2015
- Home Health Care Expenditures, Percent Distribution and Per Capita Amounts, U.S.: Selected Calendar Years 1980-2015
- Nursing Home Care Expenditures and Average Annual Percent Change, U.S.: Selected Calendar Years 1980-2015
- Nursing Home Care Expenditures, Percent Distribution and Per Capita Amount: Selected Calendar Years 1980-2015
- U.S. Prescription Drug Expenditures and Average Annual Percent Change: Selected Calendar Years 1990-2015
- U.S. Prescription Drug Expenditures, Percent Distribution and Per Capita Amount: Selected Calendar Years 1980-2015
- Index Levels of Medical Prices, U.S.: 2001-2005
- III. Medicare & Medicaid
- Federal Spending on Medicare and Medicaid: 2003-2010
- Number of Medicare Beneficiaries 1970-2030
- Medicare Aged and Disabled Enrollees, 1980-2005
- Medicare Enrollment by Type of Coverage, 1980-2005
- U.S. Medicare Enrollment Estimates, Selected Years 2006-2080
- U.S. Medicare Enrollment Trends, Part A Hospital Insurance (HI): July 1970-2005
- U.S. Medicare Enrollment Trends, Part B Supplemental Medical Insurance (SMI): July 1970-2005
- Total Medicare Beneficiaries with Drug Coverage
- Medicare Deductible, Co-Payment and Premium Amounts, 2007
- IV. U.S. Health Insurance Coverage & the Uninsured
- Percent of Persons of All Ages Without Health Insurance Coverage, U.S.: 1997-2005
- Number and Percent of Persons Without Health Insurance Coverage, by Age Group, U.S.: 1997-2005
- People Without Health Insurance for the Entire Year, U.S.: 2003, 2004 and 2005
- Percent of Persons Under Age 65 Years Without Health Insurance Coverage, by Age Group and Sex: U.S., 2005
- Percent of Persons Under Age 65 With Public Health Plan Coverage and Private Health Insurance Coverage, by Age Group, U.S.: 1997-2005
- Percent of Persons of All Ages Without Health Insurance Coverage, by Race/Ethnicity, U.S., 2005
- Employers' Costs for Health Insurance, Amount and Percent of Total Compensation, U.S.: Selected Years 2002-2006
- V. U.S. Vital Statistics & Population Indicators
- Percent of Population By Three Age Groups, U.S.: 1950, 2000 and 2050
- Life Expectancy at Birth, U.S.
- Life Expectancy at Age 65, U.S.
- Infant Mortality Rates, U.S.: Selected Years 1985-2006
- Current Cigarette Smoking by Persons 18 Years of Age and Over According to Sex and Race: United States, Selected Years 1991-2003
- Overweight and Obesity Among Persons 20 Years of Age and Over, According to Sex, Race, and Hispanic Origin Selected Years: 1960-2002
- Chapter 3: Important Health Care Industry Contacts
- (Addresses, Phone Numbers and World Wide Web Sites)
- Chapter 4: THE HEALTH CARE 500:
- Who They Are and How They Were Chosen
- Industry List, With Codes
- Index of Rankings Within Industry Groups
- Alphabetical Index
- Index of Headquarters Location by U.S. State
- Index of Non-U.S. Headquarters Location by Country
- Index by Regions of the U.S. Where the Firms Have Locations
- Index by Firms with Operations Outside the U.S.
- Individual Data Profiles on Each of THE HEALTH CARE 500
- Additional Indexes
- Index of Hot Spots for Advancement for Women/Minorities
- Index by Subsidiaries, Brand Names and Selected Affiliations
- PLUNKETT’S BIOTECH & GENETICS INDUSTRY ALMANAC 2007
- A Short Biotech & Genetics Industry Glossary
- Introduction
- How to Use This Book
- Chapter 1: Major Trends Affecting the Biotech & Genetics Industry
- 1) A Short History of Biotechnology
- 2) The State of the Biotechnology Industry Today
- 3) Rising Interest in Ethanol as a Fuel gives Biotech a Boost
- 4) New Money Pours into Biotech Firms
- 5) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms
- 6) From India to Singapore to China, Nations Compete Fiercely in Biotech Development
- 7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine
- 8) New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow
- 9) Pharmaceutical Costs Soar in U.S., Controversy over Drug Prices Rages On
- 10) Biotech Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age
- 11) Biogenerics are in Limbo in the U.S.
- 12) Breakthrough Drug Delivery Systems Evolve
- 13) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race
- 14) Stem Cell Funding Trickles at the Federal Level While a Few States Create Funding of Their Own
- 15) Stem Cells—Therapeutic Cloning Techniques Advance
- 16) Stem Cells—A New Era of Regenerative Medicine Looms
- 17) Nanotechnology Converges with Biotech
- 18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy
- 19) Focus on Vaccines to Counter Potential Bioterror Attacks in the U.S.
- 20) Ethical Issues Abound
- 21) Technology Discussion—Genomics
- 22) Technology Discussion—Proteomics
- 23) Technology Discussion—Microarrays
- 24) Technology Discussion—DNA Chips
- 25) Technology Discussion—SNPs (“Snips”)
- 26) Technology Discussion—Combinatorial Chemistry
- 27) Technology Discussion—Synthetic Biology
- 28) Technology Discussion—Recombinant DNA
- 29) Technology Discussion—Polymerase Chain Reaction (PCR)
- Chapter 2: Biotech & Genetics Industry Statistics
- Biotech Industry Overview
- Largest Global Pharmaceutical Companies
- Profile of U.S. Public Biotech Companies, 2001-2005
- U.S. Biotech Industry Financing, 1997-2005
- Wage and Employment Estimates for Life, Physical and Social Science Employees in the
- Pharmaceutical Industry 2005
- National Health Expenditure Amounts, By Type of Expenditure, U.S.: Selected Calendar Years 1980-2015
- Global R&D Investments by Research-Based Pharmaceutical Companies: 1970-2005
- U.S. National Science Foundation Biological Science Research Funding, Fiscal Year 2005-2007
- U.S. Prescription Drug Expenditures, Percent Distribution and Per Capita Amount: Selected CalendarYears 1980-2015
- A Closer Look at the Drug Discovery and Development Process
- The U.S. Drug Discovery and Approval Process
- Domestic R&D Spending as a Percentage of Domestic Sales, U.S. Research-Based Pharmaceutical Companies: Selected Years 1970-2005
- Annual Percent Change in U.S. Research & Development Spending by Research-Based Pharmaceutical Companies, 1980-2005
- R&D Spending By Function, U.S. Research-based Pharmaceutical Companies: 2004
- U.S. FDA Approval Times for New Drugs 1993-2005
- U.S. FDA Approval Times for New Molecular Entities (NMEs*), 1993-2005
- U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME*) Approvals, 1993-2005
- Total U.S. Biotechnology Patents Granted Per Year, 1989-2005
- Generics' Share of the U.S. Drug Market 1984-2005
- Global Agricultural Biotech At A Glance, 2005
- Chapter 3: Important Biotech & Genetics Industry Contacts
- (Addresses, Phone Numbers and World Wide Web Sites)
- Chapter 4: THE BIOTECH 400
- Who They Are and How They Were Chosen
- Industry Codes
- Index of Rankings Within Industry Groups
- Alphabetical Index
- Index of Headquarters Location by U.S. State
- Index of Non-U.S. Headquarters Location by Country
- Index by Regions of the U.S. Where the Firms Have Locations
- Index by Firms with Operations Outside the U.S.
- Individual Profiles on Each of THE BIOTECH 400
- Additional Indexes
- Index of Hot Spots for Advancement for Women/Minorities
- Index by Subsidiaries, Brand Names and Selected Affiliations
AbstractThis combination special contains two of our popular industry almanacs: Plunkett’s Health Care Industry Almanac 2007 and Plunkett’s Biotech & Genetics Industry Almanac 2007 for one low price. Plunkett’s Health Care Industry Almanac is the only complete reference to the American Health Care Industry and its leading corporations. Whatever your purpose for researching the health care field, you’ll find this award-winning reference book to be a valuable guide. No other source provides this massive book’s easy-to-understand comparisons of national health expenditures, emerging technologies, patient populations, hospitals, clinics, corporations, research, Medicare, Medicaid, managed care, and many other areas of vital importance. Included in the market research sections are dozens of statistical tables covering every aspect of the industry, from Medicare expenditures to hospital utilization, from insured and uninsured populations to revenues to health care expenditures as a percent of GDP. A special area covers vital statistics and health status of the U.S. population. The corporate analysis section features in-depth profiles of the ""Health Care 500""; the 500 largest and most successful for-profit firms within the health care system, from the leading companies in pharmaceuticals to the major managed care companies. Details for each corporation include growth plans, divisions, subsidiaries, brand names, competitive advantage and financial results--as well as executives by title and valuable contact information such as phone, fax, website and address.
Plunkett's Biotech & Genetics Industry Almanac 2007 is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services. This new book contains complete profiles of the leading biotech companies, in-depth chapters on trends in genetics, technologies, statistics and finances, a handy glossary and thorough indexes.
Plunkett's Biotech & Genetics Industry Almanac, our easy-to-understand reference to the biotech and genetics industry, is an absolutely vital addition to your office. For the first time, in one carefully-researched volume, you'll get all of the data you need. Topics include: A Short History of Biotechnology; The State of the Biotechnology Industry Today; Biotechnology funding and investments; Patents; Biotech activities in Singapore and China; FDA; Gene Therapies; Personalized Medicine; Systems Biology; Drug Development; Clinical Trials; Controversy over Drug Prices; Stem Cells Research; Therapeutic Cloning; Regenerative Medicine Nanotechnology; Agricultural Biotechnology; Drug Delivery Systems; BioShield; Ethical Issues.
The book also includes complete profiles on over 400 Biotech & Genetics companies, our own unique list of companies that are the leaders in biotechnology. These are the largest, most successful corporations in all facets of this exploding business. All of the corporate profile information is indexed and cross-indexed, including contact names, addresses, Internet addresses, fax numbers, toll-free numbers, plus growth and hiring plans, finances, research, marketing, technology, acquisitions and much more for each firm. Purchasers of either the book or PDF version can receive a free copy of the company profiles database on CD-ROM, enabling key word search and export of key information, addresses, phone numbers and executive names with titles for every company profiled.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
